Paraneoplastic pemphigus in children and adolescents

British Journal of Dermatology

Volumn 147, Issue 4, 2002, Pages 725-732

  Mimouni, D ^a   Anhalt, G J ^a   Lazarova, Z ^a   Aho, S ^b   Kazerounian, S ^b   Kouba, D J ^a   Mascaro Jr , J M ^c   Nousari, H C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Castleman's disease; Children; Lichenoid dermatitis; Paraneoplastic syndrome; Pemphigus; Plakin protein

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; DESMOGLEIN 1 ANTIBODY; DESMOGLEIN 2 ANTIBODY; DESMOPLAKIN; DESMOPLAKIN ANTIBODY; ENVOPLAKIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; PERIPLAKIN; PLAKIN ANTIBODY; PLECTIN; PLECTIN ANTIBODY; UNCLASSIFIED DRUG;

ACANTHOLYSIS; ADOLESCENCE; ADOLESCENT; ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNE DISEASE; BLOOD ANALYSIS; BRONCHIOLITIS; CHILDHOOD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEATH; DERMATITIS; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN DEPOSITION; IMMUNOPATHOLOGY; IMMUNOPRECIPITATION; LICHENOID; LUNG INJURY; MALE; MOUTH MUCOSA; MUCOSA INFLAMMATION; PARANEOPLASTIC PEMPHIGUS; PRIORITY JOURNAL; SCHOOL CHILD; SKIN TUMOR;

ADOLESCENT; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHILD; CYTOSKELETAL PROTEINS; DESMOGLEIN 1; DESMOGLEINS; DESMOPLAKINS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GIANT LYMPH NODE HYPERPLASIA; HUMANS; MALE; MEMBRANE PROTEINS; MOUTH MUCOSA; PARANEOPLASTIC SYNDROMES; PEMPHIGUS; PLAKINS; PROTEIN PRECURSORS; STOMATITIS;

EID: 0036404777     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.04992.x     Document Type: Article

References (33)

1. Anhalt GJ, Kim SC, Stanley JR et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990; 323: 1729-35.
2. Anhalt GJ. Paraneoplastic pemphigus: The role of tumours and drugs. Br J Dermatol 2001; 144: 1102-4.
3. Anhalt GJ. Paraneoplastic pemphigus. Adv Dermatol 1997; 12: 77-96.
4. Chiewchanvit S, Hashimoto T, Chaiwun B, Nishikawa T. A pemphigus case with long term survival, implicating the spectrum between paraneoplastic pemphigus and pemphigus vulgaris. Int J Dermatol 1997; 36: 957-8.
5. Rybojad M, Leblanc T, Flageul B et al. Paraneoplastic pemphigus in a child with a T-cell lymphoblastic lymphoma. Br J Dermatol 1993; 128: 418-22.
6. Lemon MA, Weston WL, Huff JC. Childhood paraneoplastic pemphigus associated with Castleman's tumour. Br J Dermatol 1997; 136: 115-17.
7. Jordon RE, Triftshauser CT, Schroeter AL. Direct immunofluorescent studies of pemphigus and bullous pemphigoid. Arch Dermatol 1971; 103: 486-91.
8. Stanley JR, Koulu L, Thivolet C. Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies. J Clin Invest 1984; 74: 313-20.
9. Ishii K, Amagai M, Hall RP et al. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J Immunol 1997; 159: 2010-7.
10. Nousari HC, Deterding R, Wojtczack H et al. The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med 1999; 340: 1406-10.
11. Aho S, Mahoney MG, Uitto J. Plectin serves as an autoantigen in paraneoplastic pemphigus. J Invest Dermatol 1999; 113: 422-3.
12. Ruhrberg C, Hajibagheri MA, Simon M et al. Envoplakin, a novel precursor of the cornified envelope that has homology to desmoplakin. J Cell Biol 1996; 134: 715-29.
13. Mahoney MG, Aho S, Uitto J, Stanley JR. The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin. J Invest Dermatol 1998; 111: 308-13.
14. Proby C, Fujii Y, Owaribe K et al. Human autoantibodies against HD1/plectin in paraneoplastic pemphigus. J Invest Dermatol 1999; 112: 153-6.
15. Ohyama M, Amagai M, Hashimoto T et al. Clinical phenotype and anti-desmoglein autoantibody profile in paraneoplastic pemphigus. J Am Acad Dermatol 2001; 44: 593-8.
16. Amagai M, Nishikawa T, Nousari HC et al. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest 1998; 102: 775-82.
17. Bowen GM, Peters NT, Fivenson DP et al. Lichenoid dermatitis in paraneoplastic pemphigus: A pathogenic trigger of epitope spreading? Arch Dermatol 2000; 136: 652-6.
18. Castleman B, Toww VW. Case records of the Massachusetts General Hospital. N Engl J Med 1954; 250: 26-30.
19. Parez N, Bader-Meunier B, Roy CC, Dommergues JP. Paediatric Castleman disease: Report of seven cases and review of the literature. Eur J Pediatr 1999; 158: 631-7.
20. Bowne WB, Lewis JJ, Filippa DA et al. The management of unicentric and multicentric Castleman's disease: A report of 16 cases and a review of the literature. Cancer 1999; 85: 706-17.
21. Kim SC, Chang SN, Lee IJ et al. Localized mucosal involvement and severe pulmonary involvement in a young patient with paraneoplastic pemphigus associated with Castleman's tumour. Br J Dermatol 1998; 138: 667-71.
22. Jansen T, Plewig G, Anhalt GJ. Paraneoplastic pemphigus with clinical features of erosive lichen planus associated with Castleman's tumor. Dermatology 1995; 190: 245-50.
23. Hsiao C-J, Hsu MM-L, Lee JY-Y et al. Paraneoplastic pemphigus in association with a retroperitoneal Castleman's disease presenting with a lichen planus pemphigoides-like eruption. A case report and review of literature. Br J Dermatol 2001; 144: 372-6.
24. Carrington PA, Anderson H, Harris M et al. Autoimmune cytopenias in Castleman's disease. Am J Clin Pathol 1990; 94: 101-4.
25. Curioni S, D'Amico M, Quartagno R et al. Castleman's disease with nephrotic syndrome, amyloidosis and autoimmune manifestations. Nephrol Dial Transplant 2001; 16: 1475-8.
26. Higashi K, Matsuki Y, Hidaka T et al. Primary Sjögren's syndrome associated with hyaline-vascular type of Castleman's disease and autoimmune idiopathic thrombocytopenia. Scand J Rheumatol 1997; 26: 482-4.
27. Suwannaroj S, Elkins SL, McMurray RW. Systemic lupus erythematosus and Castleman's disease. J Rheumatol 1999; 26: 1400-3.
28. Beck JT, Hsu SM, Wijdenes J et al. Alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med 1994; 330: 602-5.
29. Raison-Peyron N, Meunier L, Joly P et al. Paraneoplastic pemphigus associated with myasthenia gravis and Castleman's tumour. Eur J Dermatol 1997; 7: 371-3.
30. Nguyen VT, Ndoye A, Bassler KD et al. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: A reappraisal of paraneoplastic pemphigus. Arch Dermatol 2001; 137: 193-206.
31. Robinson ND, Hashimoto T, Amagai M, Chan LS. The new pemphigus variants. J Am Acad Dermatol 1999; 40: 763-6.
32. Oursler JR, Labib RS, Ariss-Abdo L et al. Human autoantibodies against desmoplakins in paraneoplastic pemphigus. J Clin Invest 1992; 89: 1775-82.
33. Hashimoto T, Amagai M, Watanabe K et al. Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Invest Dermatol 1995; 104: 829-34.